Capital Performance Advisors LLP 10x Genomics, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 1,555 shares of TXG stock, worth $25,144. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,555Holding current value
$25,144% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
287Shares Held
94.9MCall Options Held
162KPut Options Held
107K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$174 Million2.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$165 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$103 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$103 Million1.67% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$103 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.54B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...